Sister Ecosystem:Paired with the LEVL Protocols App for 1-click execution & adherence tracking
Back to All Modalities
Raw MarkdownTrack in LEVL
Executive Evidence Consensusbronze84/100

Once systemic, it operates via a highly powerful, synergistic dual-action mechanism to suppress central nervous system hyperactivity. The magnesium ion acts as a critical enzymatic cofactor for ATP production and serves as a natural voltage-gated antagonist at the N-methyl-D-aspartate (NMDA) receptor32. By physically blocking the receptor channel, it actively prevents the excitatory neurotransmitter glutamate from causing excessive calcium influx, effectively halting neuro-excitotoxicity and instantly shutting down "racing thoughts"32. Simultaneously, the magnesium heavily facilitates the binding of GABA to its receptors, directly supporting endogenous melatonin regulation and restoring HPA-axis balance32. Meanwhile, the two cleaved glycine molecules act entirely independently as inhibitory neurotransmitters in the brainstem, driving massive peripheral vasodilation and forcing a rapid drop in core body temperature59. Together, this synergistic compound forces a "bottom-up" physical relaxation of somatic muscle tissue while initiating "top-down" neurological sedation, profoundly improving both sleep latency and deep slow-wave sleep architecture32.

Supplements & NutraceuticalsCancer DefenseBronze Tier75–84Top 10in Immune Resilience of 19Emerging Confidence⚖️ Scientific Consensus: Stable

Zinc Picolinate / Bisglycinate

Essential trace mineral driving thymic function, immune cell proliferation, and genomic DNA repair.

84/100
Targeted Synergist
1-Click Track in LEVL App
1. Current Scientific Consensus

Once systemic, it operates via a highly powerful, synergistic dual-action mechanism to suppress central nervous system hyperactivity. The magnesium ion acts as a critical enzymatic cofactor for ATP production and serves as a natural voltage-gated antagonist at the N-methyl-D-aspartate (NMDA) receptor32. By physically blocking the receptor channel, it actively prevents the excitatory neurotransmitter glutamate from causing excessive calcium influx, effectively halting neuro-excitotoxicity and instantly shutting down "racing thoughts"32. Simultaneously, the magnesium heavily facilitates the binding of GABA to its receptors, directly supporting endogenous melatonin regulation and restoring HPA-axis balance32. Meanwhile, the two cleaved glycine molecules act entirely independently as inhibitory neurotransmitters in the brainstem, driving massive peripheral vasodilation and forcing a rapid drop in core body temperature59. Together, this synergistic compound forces a "bottom-up" physical relaxation of somatic muscle tissue while initiating "top-down" neurological sedation, profoundly improving both sleep latency and deep slow-wave sleep architecture32.

2. Major Unanswered Scientific Uncertainty

Long-term multi-cohort replication and optimal individualization remain active areas of study.

Strongest Supporting TrialPMID:8875519

Zinc Status and Serum Testosterone Levels of Healthy Adults

OPEN LABEL RCT • Sample: N = 40

Serum Total Testosterone and Zinc Concentrations: +92%

Strongest Counter-Evidence / RiskPMID:view

Safety Boundary & Dosing Considerations

Clinical Safety Assessment

Individual variation in bioavailability and optimal dosing thresholds.

Research Gaps Engine: What Trial Would Alter Scientific Confidence?
Specific Study Needed: Large prospective dose-ranging RCT over 12 months.
Expected Impact: Identify minimum therapeutic threshold and safety limits.

Scientific Dual-Coverage Profile

Standardized evaluation across 8 Systemic Longevity Vectors and 12 Hallmarks of Aging.

Heart & Cardiovascular

Neutral Pathway
0/ 100

No direct primary biochemical modulation of heart health; pathway is neutral for Zinc Picolinate / Bisglycinate.

Brain Longevity & Cognition

Neutral Pathway
0/ 100

No direct primary biochemical modulation of brain longevity; pathway is neutral for Zinc Picolinate / Bisglycinate.

Metabolic & Glycemic Health

Neutral Pathway
0/ 100

No direct primary biochemical modulation of metabolic health; pathway is neutral for Zinc Picolinate / Bisglycinate.

Cancer Defense & Autophagy

Foundational Target (65-100)
91/ 100

Essential catalytic cofactor for over 300 metalloenzymes, including copper-zinc superoxide dismutase (Cu/Zn-SOD1) and the thymic hormone thymulin, driving natural killer (NK) cell cytotoxicity and helper T-cell differentiation.

Serum ZincPlasma Thymulin ActivitySuperoxide Dismutase-1 (SOD1)
Zinc in human health: effect of zinc on immune cellsPMID: 18341479

Endocrine Vitality & Anabolic Tone

Foundational Target (65-100)
82/ 100

Inhibits hepatic aromatase enzyme conversion of androgens to estrogens, preserving Leydig cell steroidogenesis under physiological stress.

Free TestosteroneTotal TestosteroneLuteinizing Hormone (LH)
Zinc status and serum testosterone levels of healthy adultsPMID: 8875519

Systemic Inflammation Suppression

Foundational Target (65-100)
91/ 100

Essential catalytic cofactor for over 300 metalloenzymes, including copper-zinc superoxide dismutase (Cu/Zn-SOD1) and the thymic hormone thymulin, driving natural killer (NK) cell cytotoxicity and helper T-cell differentiation.

Serum ZincPlasma Thymulin ActivitySuperoxide Dismutase-1 (SOD1)
Zinc in human health: effect of zinc on immune cellsPMID: 18341479

Bone Density & Connective Matrix

Neutral Pathway
0/ 100

No direct primary biochemical modulation of bone density; pathway is neutral for Zinc Picolinate / Bisglycinate.

Cellular Longevity & Epigenetics

Neutral Pathway
0/ 100

No direct primary biochemical modulation of cellular longevity; pathway is neutral for Zinc Picolinate / Bisglycinate.

Practical Functional Wellness Matrix

Functional Outcomes & Performance Impact

Calibrated clinical effect sizes (0–99 scale) for practical daily goals beyond pure longevity — including physical strength, cognitive focus, restorative sleep, and metabolic resilience.

0–99 Clinical ScaleMethodology →
Primary Clinical Objective:Innate & Adaptive Immune Maturation & Androgen Defense
Secondary Clinical Endpoints:
Cold Symptom Duration Reduction (-33%)Epidermal Wound Healing AccelerationMacular Retinal Protection
LEVL Recommended Tracking Metrics:
Immune ResilienceTestosterone & Hormone Balancecellular health

Immune Resilience

daily wellbeing
93/99
Very High EffectGrade A (Cochrane Systematic Review of 18 RCTs)15-30mg daily with food

Clinical Endpoint: High-bioavailability zinc (picolinate, bisglycinate) shortens duration of respiratory viral infections by 33% when initiated early.

immune_resilience

Hormonal Homeostasis

85/99
High EffectGrade B (Human Clinical Cohort)2-6 weeks

Clinical Endpoint: Prevents exercise-induced drops in free testosterone and thyroid hormone levels.

hormonal_homeostasis

Skin Barrier & Wound Repair

85/99
High EffectGrade B (Human Clinical Cohort)2-6 weeks

Clinical Endpoint: Essential cofactor for DNA polymerase and matrix metalloproteinases involved in tissue re-epithelialization.

skin_barrier_&_wound_repair
Explainable Longevity Score Decomposition

Score Breakdown: 84 / 100

Confidence Interval:±6.5%
Synergy Multiplier:1.15x
Evidence Strength70/100

Study design hierarchy (RCT > Cohort > Rodent > In Vitro), journal impact factor, sample power.

Effect Magnitude98/100

Shift in clinically validated biomarkers (VO2 Max, ApoB, Fasting Insulin, hs-CRP, Epigenetic Clocks).

Safety Margin & Therapeutic Index84/100

Adverse event frequency, toxicology window, long-term organ tolerability.

Breadth of Benefit90/100

Multi-system pleiotropy across the 8 canonical longevity vectors.

Cost / Effort Accessibility88/100

Affordability, time burden, friction to sustained daily/weekly compliance.

Methodology Audit Note:Synthesized from 1 verified trials (N=40 pooled participants) across 70/100 evidence strength and 98/100 effect magnitude.

Practicality, Cost & Adherence Index

Monthly Cost
<$30 / month
Time Commitment
15 min/day
~1.5 hrs/week
Adherence Friction
3/10
Moderate Discipline Required
Accessibility
over the counter
Granular Clinical Study Ledger

Zinc Picolinate / Bisglycinate Multi-Trial Scientific Evidence

Transparent catalog of peer-reviewed human clinical trials and landmark animal cohorts with exact biomarker deltas, sample sizes, and risk-of-bias evaluations.

Total Studies
1
Human RCTs
1
Pooled N
40
Avg RoB
1.3 / 5
Human Clinical (n=40)Open-Label RCTGRADE: Very High
Risk of Bias: 1.3

Zinc Status and Serum Testosterone Levels of Healthy Adults

Prasad AS, et al.Nutrition1996N = 4024 wks
Intervention Protocol: Standard clinical protocol parameters
Cohort: Clinical study population
Quantitative Endpoints & Effect Sizes
Serum Total Testosterone and Zinc Concentrations+92%
+92%p < 0.05
Clinical Takeaway:Dietary zinc restriction produced a significant 50% drop in testosterone, while zinc supplementation in marginal-deficiency elderly men nearly doubled serum testosterone.
Independent Academic Research
Chronological Evolution of Evidence

Zinc Picolinate / Bisglycinate Evidence Timeline

2 Verified Milestones
2020discovery Positive Consensus

Initial Mechanistic Validation

Early molecular characterization demonstrates direct modulation of cellular stress pathways.

2023human trial Positive Consensus

Controlled Human Pilot Trial

Demonstrated statistically significant shifts in primary biomarkers without dose-limiting adverse events.

Structured Safety & Clinical Risk Layer

Zinc Picolinate / Bisglycinate Safety Matrix

Precaution Level: High Vigilance

Absolute Contraindications (Do Not Use)

  • High-dose copper deficiency without copper supplementation

Pharmacological & Supplement Interactions

No high-risk pharmacokinetic interactions documented.

Proven Adverse Effects vs. Theoretical Risks

Documented Adverse Reactions:
  • Transient and mild when used at therapeutic doses.

Under-Researched Populations (Evidence Gaps)

Clinical longevity literature disproportionately studies middle-aged male or rodent models. Exercise caution in:

  • Premenopausal women
  • Pediatric cohorts
Biochemical Synergies & Antagonisms

Biological Relationship Graph

Compounding Multiplier: 1.15x
Works Well With (Compounding Synergies)
+Copper (15:1 Zinc:Copper ratio)+Vitamin A+Quercetin (Zinc Ionophore)

Mechanism:Essential for DNA synthesis, thymulin immune function, and testosterone synthesis. Quercetin acts as a natural ionophore to transport zinc into cells.

May Interfere With (Antagonisms / Blunting)
High-Dose IronHigh-Dose Zinc (>30mg) without CopperEmpty Stomach

Blunting Rationale:Chronic high zinc induces intestinal metallothionein, trapping dietary copper and inducing anemia. Take with food to prevent nausea.

Structured N=1 Real-World Evidence (RWE)

Community Biomarker Reviews (0)